Shock Therapeutics Biotech

STBI is an early-stage biotech company developing medicines to improve critical care outcomes, by stabilizing patients and buying time for treatment and recovery!

THE PROBLEM

Hemorrhagic Shock is the condition that precedes death in almost all cases of fatal injury & trauma.

The U.S.

Over 250,000

Leading cause of death under 45 annually killing

CDC

The World

4.4

Million

Annually injury and violence kill an estimated

WHO

The Military

Preventable

Deaths

Leading cause of potentially

Eastridge & Holcomb 2019

Once shock sets in, it is incredibly hard to reverse. We believe this is because the current treatment options are for the symptoms of shock - not for shock itself.